Dr. Auro Viswabandya
MBBS, MD, DM, FRCP, FRCPC, DRCPSC
Staff Physician, Hans Messner Allogeneic Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre
- Academic Affiliation
Assistant Professor, Faculty of Medicine, University of Toronto
- Education and Training
- 2021 Jul – 2023 May MSc, Master of Healthcare Quality and Safety (MSHQS), Dept of Medicine, Harvard Medical School, Boston, Massachusetts, United States
- 2009 Oct – 2012 Jun Clinical Fellow, Malignant Hematology and Stem Cell Transplantation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 2001 Apr – 2004 Mar D.M, Clinical Hematology, Christian Medical College, Vellore, The MGR Medical University, Vellore, Tamil Nadu, India
- 2001 Apr – 2004 Mar Specialty Training in Hematology, Department of Clinical Hematology, Christian Medical College, Vellore, Tamil Nadu, India
- 1996 Sep – 1999 Sep MD, General Medicine, MKCG Medical College, Berhampur University, Berhampur, Orissa, India
- 1989 Sep – 1995 Dec MBBS, SCB Medical College, Cuttack, Utkal University, Bhubaneswar, Orissa, India
- CLINICS
Allogeneic Stem Cell Transplant
- Languages
- English
- Bengali
- Hindi
- Oriya
- Contact Information
- Assistant Name: Roshanna Bradder
- Assistant Contact: 416-946-4501 x 3256
- Fax: 416-946-4563
- Publications
- Central Nervous System Manifestations of Graft-Versus-Host Disease. – Search Results – PubMed
- Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis – PubMed
- Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation – PubMed
- Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies – PubMed
- A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation – PubMed